期刊文献+

术前超敏C反应蛋白联合中性粒细胞/淋巴细胞比值在转移性胃癌中的预后预测价值 被引量:4

Prognostic value of preoperative high-sensitivity C-reactive protein combined with neutrophil/lymphocyte ratio in metastatic gastric cancer
下载PDF
导出
摘要 目的探讨超敏C反应蛋白联合中性粒细胞/淋巴细胞比值(hsC-NLR)在预测接受手术治疗的转移性胃癌患者预后中的价值。方法回顾性收集2013年1月至2021年9月在中山大学附属第六医院接受手术治疗的转移性胃癌患者的临床病理资料。根据surv_cutpoint函数确定hsC-NLR的最佳截断值,将患者分为低hsC-NLR组(n=42)和高hsC-NLR组(n=136)。通过Kaplan-Meier法绘制生存曲线,采用log-rank显著性检验计算不同hsC-NLR亚组间生存率差异。采用单因素和多因素Cox回归分析确定影响总生存的独立危险因素。结果最终被纳入本研究的转移性胃癌患者共有178例。hsC-NLR的最佳截断值为2.71,其中低hsC-NLR组有42例,高hsC-NLR组有136例。生存分析结果显示,低hsC-NLR组与高hsC-NLR组的患者3年总生存率分别为20.7%和9.52%,两组之间的差异具有统计学意义(χ^(2)=4.3,P=0.037)。多因素Cox回归分析结果显示,hsC-NLR>2.71(HR:1.632,95%CI:1.035~2.574,P=0.035)、腹膜转移(HR:1.910,95%CI:1.194~3.054,P=0.007)和白蛋白<40 g/L(HR:1.509,95%CI:1.035~2.202,P=0.033)为转移性胃癌患者预后的独立危险因素。结论hsC-NLR可作为转移性胃癌患者的独立预后因素,术前hsC-NLR>2.71提示患者预后不良。 Objective Patients with metastatic gastric cancer(mGC)has a high incidence and poor prognosis.It is known that inflammatory reactions are closely related to tumor development and progression.This study aims to explore the value of high-sensitivity C-reactive protein combined with neutrophil-lymphocyte ratio(hsC-NLR)in predicting the prognosis of patients with mGC who underwent surgery.Method The clinicopathological records of patients who underwent surgery between January 2013 and September 2021 in the Sixth affiliated hospital of Sun Yat-sen University were collected and analyzed retrospectively.According to the surv cutpointfunction,the optimal cut-off value of hsC-NLR was determined,and the patients were divided into low hsC-NLR group(n=42)and high hsC-NLR group(n=136).Overall survival(OS)was analyzed by Kaplan-Meier method.Log-rank test was employed to test the differences in the survival rates between the subgroups.Univariate and multivariate Cox regression analyses were used to identify independent risk factors for OS.Result A total of 178 patients with mGC were finally included in this cohort.The cut-off value of hsC-NLR was 2.71,with 42 cases in the low hsC-NLR group and 136 cases in the high hsC-NLR group.Survival analysis showed that the 3-year OS rates of patients with low hsC-NLR and high hsC-NLR were 20.7%and 9.52%,respectively,and the difference between the two groups was statistically significant(χ^(2)=4.3-P=0.037).Multivariate Cox regression analysis showed that hsC-NLR>2-71(HR:1.632-95%CI:1.035-2.574-P=0.035)-peritoneal metastasis(HR:1.910-95%CI:1.194-3.054-P=0.007)and albumin<40 g/L(HR:1.509-95%CI:1.035-2.202-P=0.033)were independent risk factors for the prognosis of patients with mGC.Conclusion hsC-NLR is an independent prognostic factor for patients with mGC-and a preoperative hsC-NLR greater than 2.71 indicates poor prognosis.
作者 王新友 靳龙洋 熊志中 陈华显 练磊 Wang Xinyou;Jin Longyang;Xiong Zhizhong;Chen Huaxian;Lian Lei(Department of Gastrointestinal Surgery,the Sixth Affiliated Hospital,Sun Yat-sen University,Guangzhou 510655,Guangdong China)
出处 《消化肿瘤杂志(电子版)》 2022年第3期291-296,共6页 Journal of Digestive Oncology(Electronic Version)
关键词 超敏C反应蛋白 中性粒细胞/淋巴细胞比值 转移性胃癌 预后 生物标志物 High-sensitivity C-reactive protein Neutrophil-lymphocyte ratio Metastatic gastric cancer Prognosis Biomarker
  • 相关文献

参考文献2

二级参考文献32

  • 1Wei Ren,Jin Yu,Zhi-Mei Zhang,Yuan-Kun Song,Yi-Hui Li,Lei Wang.Missed diagnosis of early gastric cancer or high-grade intraepithelial neoplasia[J].World Journal of Gastroenterology,2013,19(13):2092-2096. 被引量:64
  • 2操礼群.进展期胃癌术后早期双途径化疗的临床应用[J].实用肿瘤学杂志,2007,21(2):144-145. 被引量:4
  • 3吴晖,何裕隆,蔡世荣,吴文辉,王昭,宋武,张常华,詹文华.胃癌腹膜种植临床病理特征及手术对预后的影响[J].中国实用外科杂志,2007,27(11):879-882. 被引量:14
  • 4Xiao-Jiang Wu,Peng Yuan,Zi-Yu Li,Zhao-De Bu,Lian-Hai Zhang,Ai-Wen Wu,Xiang-Long Zong,Shuang-Xi Li,Fei Shan,Xin Ji,Hui Ren,Jia-Fu Ji.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves the survival of gastric cancer patients with ovarian metastasis and peritoneal dissemination[J]. Tumor Biology . 2013 (1)
  • 5James J. Mezhir MD,Manish A. Shah MD,Lindsay M. Jacks MS,Murray F. Brennan MD,Daniel G. Coit MD,Vivian E. Strong MD.Positive Peritoneal Cytology in Patients with Gastric Cancer: Natural History and Outcome of 291 Patients[J]. Annals of Surgical Oncology . 2010 (12)
  • 6Xiao‐JunYang,YanLi,YutakaYonemura.Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center[J]. J. Surg. Oncol. . 2010 (6)
  • 7Xiao-Jun Yang MD,Yan Li MD, PhD,Alaa Hammed al-shammaa Hassan MD,Guo-Liang Yang MD,Shao-Yang Liu MD,Yu-Lan Lu MD,Jing-Wei Zhang MD,Yukata Yonemura MD, PhD.Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival in Selected Patients with Peritoneal Carcinomatosis from Abdominal and Pelvic Malignancies: Results of 21 Cases[J]. Annals of Surgical Oncology . 2009 (2)
  • 8P.H. Sugarbaker.Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome[J]. European Journal of Surgical Oncology . 2001 (3)
  • 9SHIGERU FUJIMOTO,RAM DHOJ SHRESTHA,MASASHI KOKUBUN,MASAYASU OHTA,MAKOTO TAKAHASHI,KOKURIKI KOBAYASHI,SOHZABURO KIUCHI,KATSUJI OKUI,TAKEYOSHI MIYOSHI,NOBORU ARIMIZU,HIROYOSHI TAKAMIZAWA.Intraperitoneal Hyperthermic Perfusion Combined with Surgery Effective for Gastric Cancer Patients with Peritoneal Seeding[J]. Annals of Surgery . 1988 (1)
  • 10Japanese Gastric Cancer Association.Japanese gastric cancer treat-ment guidelines 2010 (ver.3). Gastric Cancer . 2011

共引文献210

同被引文献44

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部